| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Based in Melbourne, Australia, Lorikeet Therapeutics is working on agonists of the melanocortin 5 receptor to drive insulin independent glucose uptake into skeletal muscle. Reducing the need for people living with Type 1 diabetes to use insulin. |
| Category: | Health & biotech |
| URL: | https://lorikeettx.com/ |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | |
| Address: | RINGWOOD NORTH VIC 3134 |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | |
| Founders: |
No items found
|
| Awards won: | |
